Miralles Gines Diego — SEC insider filings
SEC reporting owner CIK 1773413. 8 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2020-09-11 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 1,043 shares, $4,080 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 1,043 shares @ $3.91 ($4,080) in Artiva Biotherapeutics, Inc., filed 2026-11-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | President & Head of R&D | 4 | — | 1 leg · 1,043 sh · $4,080 | 5 |
| Contineum Therapeutics, Inc. (CTNM) | Director | 3 | — | — | 3 |
| NeuBase Therapeutics, Inc. (NBSE) | Director | 1 | — | — | 1 |
Insider filings — Miralles Gines Diego
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Sale (S): 1,043 @ $3.91 | EDGAR |
| 2026-09-11 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/award (A): 45,000 @ $0 · Grant/award (A): 135,000 (derivative) @ $0 | EDGAR |
| 2026-06-26 | 4 | Contineum Therapeutics, Inc. (CTNM) | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/award (A): 77,500 @ $0 · Grant/award (A): 232,500 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Contineum Therapeutics, Inc. (CTNM) | Grant/award (A): 14,750 (derivative) @ $0 | EDGAR |
| 2025-03-17 | 4 | Contineum Therapeutics, Inc. (CTNM) | Grant/award (A): 29,500 (derivative) @ $0 | EDGAR |
| 2020-09-11 | 4 | NeuBase Therapeutics, Inc. (NBSE) | Grant/award (A): 14,634 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1773413 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs